Although the pharma industry has been relatively slow in its uptake, this began to change in 2017. It has definitely turned in the past year, and we are now seeing a far greater confidence in what data analytics and technology can do for a company’s operations.”

Jonathan Retano

FOUNDER AND CEO, PHARMAFUSION

April 01, 2019

Pharmafusion’s mission is to simplify analytics for the biopharmaceutical value chain. What was the reason behind the conception of Pharmafusion?

Pharmafusion was conceived through an understanding of the needs of pharmaceutical industry leaders and my knowledge of data management and analytics. We envisioned Pharmafusion as a platform that could provide a fully packaged experience to the user to address the frequent pain-points of pharmaceutical commercial operations. Subsequently, we developed a turnkey platform that has all the datasets for pharmaceutical analytics one requires – all on one platform. The key was to make pharma analytics as easy as watching smart TV and to flip the Pareto 80-20, which we were successful in doing.  As a result, companies can now spend more time on value-add work, such as strategy that is really going to drive their business forward rather than gathering and organizing data as this is carried out by our platform.

Could you elaborate on your award-winning Pharmafusion platforms?

We have a number of different solutions at Pharmafusion that we use to help facilitate a streamlined analytics process for our customers. SpydeRx, for example is used to monitor competitor activity in all drug classes through a daily notification of price changes, new entrants and FDA filings. Pharmafusion 360 is our award-winning, enterprise-wide data warehouse and business analytics platform that was designed for commercial pharmaceutical operations.

Our philosophy was to easily pivot the platform so it can be used in-house. For a small company that does not have the adequate infrastructure, it can be placed on the cloud. For larger companies, it is based on a subscription-based service. A unique feature of the platform is our analytics concierge. This allows for a ‘wingman’ approach to help our clients if they are in need of assistance when analyzing their data.

How does Pharmafusion differentiate its platform from other systems currently on the market?

Our differentiation has been built from the ground up with a team that really knows the pharmaceutical business. It is based on an award-winning design; it is plug and play and specific to the pharmaceutical industry. It is pre-built with over 50 subject areas that are integrated into a 360 degree view of pharma operations. This integration is the essence of Pharmafusion 360 and helps address the myopic decision making prevalent in the pharma industry. The end result is that everyone is looking at the same data and can understand the impact of business decisions across the entire organization. 

Given the general conservatism towards the uptake of technology in the pharmaceutical industry, how have you seen this change over the past two years?

In our everyday lives, the uptake of technology is very fast. Although the pharma industry has been relatively slow in its uptake, this began to change in 2017. It has definitely turned in the past year, and we are now seeing a far greater confidence in what data analytics and technology can do for a company’s operations. There has definitely been an evolution in how the industry looks at technology and the approach in housing data in the cloud.

How would you like Pharmafusion to be perceived by the market?

We have an innovative platform that was completely built from the ground up, is non-invasive and tremendously flexible. One of our challenges is getting companies to actually experience the platform. What we are trying to do is bring analytics and business intelligence onto a simple dashboard that looks like a TV screen. It is smart TV for pharmaceutical analytics operations, and once our customers have experienced the platform, they have an ‘ah-ha’ moment of what it can do for their business. For us, as we have grown over the past few years, we have found that the flexibility of the platform means it has been an easy process to scale. Being recognized as a top 10 analytics solution providers by Pharma Tech Outlook is testament to the ease of the platform.

What is your longer-term vision for Pharmafusion?

Our long-term vision for Pharmafusion is to be the gold standard for pharmaceutical analytics and to build the best pharmaceutical analytics platform out there for pharmaceutical companies of all sizes and at all stages of commercialization.  We want Pharmafusion to be the go-to for all pharmaceutical analytics.

INTERVIEWS MORE INTERVIEWS

"One of Nigeria's biggest untapped opportunities is gas development. The country has massive gas reserves that could transform its energy sector. Infrastructure investment and regulatory support will be key to unlocking this."
"Every oilfield declines without continued investment, so new owners must push hard to restore and increase output. This means significant opportunities for contractors like us in the form of asset upgrades and new projects."
"The challenge for companies is to invest in more technical support and encourage farmers to adopt them."
"Panuco has become the largest undeveloped high-grade silver primary resource in the world. With the DFS planned for H2 2025, we aim to be in production in two years."

RECENT PUBLICATIONS

Mexico Chemicals 2025 CW Release

Mexico's chemical industry faces challenges in securing a reliable feedstock supply and maintaining global competitiveness. A shift towards sustainable energy and local production could provide long-term growth opportunities, and some sectors are booming, including Mexico's dynamic chemical distribution market.

MORE PREVIOUSLY PUBLISHED

MACIG

"The JSE is engaging with the the market to originate new listings in vanadium, lithium, copper and rare earths."

SUBSCRIBE TO OUR NEWSLETTER